Rewriting the story
of human health —
one cell at a time

Empowering biomedical innovation and a new generation of cures through precision reprogrammed human cells

Cell identity coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency.

Explore our platform
bit.bio–venn_diagram–V19-Desktop bit.bio–venn_diagram–V19-Mobile

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

Learn more

ioCells™

Precision reprogrammed human iPSC-derived cells for research and drug discovery.

Discover ioCells
iocells_vial_radial_0

Latest news

Navigating the future of cell therapies with exec Kathryn Corzo Article
Navigating the future of cell therapies with exec Kathryn Corzo 30.08.2023
Published by Drug Discovery & Development
Read now
Synthego and bit.bio expand strategic partnership Press Release
Synthego and bit.bio expand strategic partnership 24.08.2023
Published by bit.bio
Read now
Disease model panel to advance Frontotemporal dementia drug discovery New product
Disease model panel to advance Frontotemporal dementia drug discovery 23.08.2023
Published by bit.bio
Read now
BlueRock Therapeutics and bit.bio announce collaboration Press Release
BlueRock Therapeutics and bit.bio announce collaboration 03.08.2023
Published by bit.bio
Read now